BPC-157 has not been proven safe or effective for any condition and is not eligible for inclusion on the 503B Bulks List for compounding. FDA Review Memorandum, 2023 In other words, BPC157 does not meet FDA standards for legal use in clinical practice
Anti-inflammatory effects protecting retinal tissues Cytokine modulation: BPC-157 reduces pro-inflammatory cytokines (IL-1, IL-6, TNF-) in injured tissues
Thakor, Stanford University How MSCs Support Maternal Health MSCs are not only abundant and easy to source but also play an active role in healing
Consequently, Dihexa remains a subject of interest within research environments that emphasize documentation, repeatability, and standardized evaluation procedures
Is IV therapy worth the money
If you're new to this whole category of ingredients, you can get up to speed on how they work in our detailed guide on peptide serums